Atlas Trials

TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors

Clinical trial NCT02650635 · TERMINATED

Trial details

NCT number
NCT02650635
Sponsor
Mayo Clinic
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Colorectal AdenocarcinomaMetastatic Pancreatic AdenocarcinomaRecurrent Breast CarcinomaRecurrent Colorectal CarcinomaRecurrent Melanoma of the SkinRecurrent Non-Small Cell Lung CarcinomaRecurrent Pancreatic CarcinomaRecurrent Renal Cell CarcinomaSolid NeoplasmStage IV Breast CancerStage IV Non-Small Cell Lung CancerStage IV Renal Cell Cancer
Start date
2016-02-05
Primary completion
2016-09-26
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.